New England Journal of Medicine· 2014Q1· Clinical trial
Albumin Replacement in Patients with Severe Sepsis or Septic Shock
- 1,321citations
- Q1SCImago
- 2014year
Short summary
In patients with severe sepsis or septic shock, administering 20% albumin alongside crystalloid solutions did not improve survival rates at 28 or 90 days compared to crystalloid solution alone.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Critical Care and Intensive Care Medicine
Critical Care and Intensive Care MedicineMedicine